title: Immune problems in central nervous system cell therapy.
abstract: Transplantation of cells and tissues to the mammalian brain and CNS has revived the interest in the immunological status of brain and its response to grafted tissue. The previously held view that the brain was an absolute "immunologically privileged site" allowing indefinite survival without rejection of grafts of cells has proven to be wrong. Thus, the brain should be regarded as a site where immune responses can occur, albeit in a modified form, and under certain circumstances these are as vigorous as those seen in other peripheral sites. Clinical cell transplant trials have now been performed in Parkinson's disease, Huntington's disease, demyelinating diseases, retinal disorders, stroke, epilepsy, and even deafness, and normally are designed as cell replacement strategies, although implantation of genetically modified cells for supplementation of growth factors has also been tried. In addition, some disorders of the CNS for which cell therapies are being considered have an immunological basis, such as multiple sclerosis, which further complicates the situation. Embryonic neural tissue allografted into the CNS of animals and patients with neurodegenerative conditions survives, makes and receives synapses, and ameliorates behavioral deficits. The use of aborted human tissue is logistically and ethically complicated, which has lead to the search for alternative sources of cells, including xenogeneic tissue, genetically modified cells, and stem cells, all of which can and will induce some level of immune reaction. We review some of the immunological factors involved in transplantation of cells to CNS.
authors.affiliation: Cambridge Center for Brain Repair and Department of Neurology, Cambridge CB2 6SP, United Kingdom.
authors.forename: Roger A
authors.initials: RA
authors.lastname: Barker
authors.forename: Håkan
authors.initials: H
authors.lastname: Widner
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells; D002493:Central Nervous System Diseases / Q000276:immunology* / Q000628:therapy*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009417:Nerve Tissue / Q000637:transplantation; D009474:Neurons / Q000637:transplantation*; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000639:trends*; D013552:Swine; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous; D015047:Zoonoses
chemical_list: D007166:Immunosuppressive Agents
references.citation: Curr Opin Immunol. 1996 Oct;8(5):681-7
references.pmid: 8902394
references.citation: Exp Neurol. 1996 Nov;142(1):36-46
references.pmid: 8912897
references.citation: Nat Med. 1997 Mar;3(3):350-3
references.pmid: 9055867
references.citation: Cell Transplant. 1997 May-Jun;6(3):213-9
references.pmid: 9171154
references.citation: Neuroscience. 1997 Jul;79(1):57-78
references.pmid: 9178865
references.citation: J Neurosci Res. 1997 Jun 1;48(5):385-96
references.pmid: 9185663
references.citation: Exp Neurol. 1997 Nov;148(1):334-47
references.pmid: 9398476
references.citation: Cell Transplant. 1997 Nov-Dec;6(6):571-7
references.pmid: 9440866
references.citation: Brain Behav Immun. 1997 Dec;11(4):245-63
references.pmid: 9512813
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: Eur J Neurosci. 1998 Aug;10(8):2595-606
references.pmid: 9767390
references.citation: Immunol Today. 1999 Feb;20(2):77-82
references.pmid: 10098326
references.citation: Nat Rev Neurosci. 2001 Jul;2(7):513-20
references.pmid: 11433376
references.citation: Genome Res. 2001 Jul;11(7):1156-66
references.pmid: 11435397
references.citation: Transplantation. 2001 Jun 27;71(12):1797-806
references.pmid: 11455261
references.citation: J Neuropathol Exp Neurol. 2001 Aug;60(8):741-52
references.pmid: 11487048
references.citation: Nat Immunol. 2001 Sep;2(9):816-22
references.pmid: 11526392
references.citation: Neuroscience. 2001;106(1):201-16
references.pmid: 11564430
references.citation: Glia. 2001 Nov;36(2):118-24
references.pmid: 11596120
references.citation: Ann N Y Acad Sci. 2001 Nov;944:226-39
references.pmid: 11797672
references.citation: Trends Immunol. 2002 Jan;23(1):23-30
references.pmid: 11801451
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2344-9
references.pmid: 11782534
references.citation: Mov Disord. 2002 Mar;17(2):233-41
references.pmid: 11921107
references.citation: Eur J Neurosci. 2002 Apr;15(7):1255-66
references.pmid: 11982636
references.citation: Xenotransplantation. 2002 Jan;9(1):68-76
references.pmid: 12005106
references.citation: Exp Neurol. 2002 May;175(1):98-111
references.pmid: 12009763
references.citation: Nat Biotechnol. 2002 Jul;20(7):689-96
references.pmid: 12089553
references.citation: Cell Transplant. 2000 Mar-Apr;9(2):273-8
references.pmid: 10811399
references.citation: Nat Neurosci. 2000 Jun;3(6):537-44
references.pmid: 10816308
references.citation: Trends Neurosci. 2000 Aug;23(8):337-44
references.pmid: 10906793
references.citation: Eur J Neurosci. 2000 Jul;12(7):2405-13
references.pmid: 10947819
references.citation: J Exp Med. 2000 Sep 18;192(6):871-80
references.pmid: 10993917
references.citation: Transplantation. 2000 Nov 15;70(9):1382-9
references.pmid: 11087157
references.citation: Prog Brain Res. 2000;127:157-88
references.pmid: 11142027
references.citation: Prog Brain Res. 2000;127:299-320
references.pmid: 11142032
references.citation: Mol Ther. 2001 Jan;3(1):36-46
references.pmid: 11162309
references.citation: N Engl J Med. 2001 Mar 8;344(10):710-9
references.pmid: 11236774
references.citation: Immunity. 2001 Apr;14(4):399-406
references.pmid: 11336685
references.citation: Immunity. 2001 Apr;14(4):437-46
references.pmid: 11336689
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6295-300
references.pmid: 11371643
references.citation: Neuroscience. 1986 Nov;19(3):685-94
references.pmid: 3796814
references.citation: Science. 1988 Jan 15;239(4837):290-2
references.pmid: 3276004
references.citation: Brain Res. 1988 Nov;472(3):287-324
references.pmid: 3066438
references.citation: Exp Brain Res. 1989;75(1):195-207
references.pmid: 2495977
references.citation: Exp Brain Res. 1989;76(1):187-97
references.pmid: 2753100
references.citation: Exp Brain Res. 1989;78(1):214-8
references.pmid: 2512178
references.citation: Trends Neurosci. 1990 Sep;13(9):366
references.pmid: 1699325
references.citation: Exp Brain Res. 1992;90(1):54-62
references.pmid: 1355744
references.citation: N Engl J Med. 1992 Nov 26;327(22):1541-8
references.pmid: 1435880
references.citation: J Exp Med. 1993 Jan 1;177(1):57-68
references.pmid: 7678116
references.citation: J Exp Med. 1993 Mar 1;177(3):597-603
references.pmid: 8436903
references.citation: Immunol Today. 1993 Oct;14(10):480-2
references.pmid: 7506033
references.citation: Neuroscience. 1993 Nov;57(2):261-74
references.pmid: 7906872
references.citation: Reg Immunol. 1993 Sep-Oct;5(5):253-68
references.pmid: 8148235
references.citation: Cell Transplant. 1993 Jul-Aug;2(4):307-17
references.pmid: 8162272
references.citation: Science. 1994 Jul 29;265(5172):674-6
references.pmid: 7518616
references.citation: Neuroscience. 1994 Oct;62(4):989-1001
references.pmid: 7845600
references.citation: N Engl J Med. 1995 Apr 27;332(17):1118-24
references.pmid: 7700284
references.citation: Neuroreport. 1994 Dec 30;6(1):49-53
references.pmid: 7703427
references.citation: Exp Brain Res. 1995;106(2):181-6
references.pmid: 8566182
references.citation: Exp Neurol. 1996 Jul;140(1):1-13
references.pmid: 8682173
references.citation: Mov Disord. 2002 May;17(3):439-44
references.pmid: 12112189
references.citation: Exp Eye Res. 2002 Jul;75(1):23-37
references.pmid: 12123634
references.citation: Xenotransplantation. 2003 Jan;10(1):41-9
references.pmid: 12535224
references.citation: Transplantation. 2003 May 15;75(9):1448-54
references.pmid: 12792495
references.citation: Ann Neurol. 2003 Sep;54(3):403-14
references.pmid: 12953276
references.citation: Xenotransplantation. 2004 Jan;11(1):60-71
references.pmid: 14962294
references.citation: Brain Res Bull. 2004 Mar 15;63(2):105-18
references.pmid: 15130699
references.citation: Adv Immunol. 1977;25:1-54
references.pmid: 345773
references.citation: Science. 1979 Mar 16;203(4385):1123-5
references.pmid: 424741
references.citation: J Exp Med. 1981 Aug 1;154(2):347-61
references.pmid: 6943285
references.citation: Microvasc Res. 1984 Jul;28(1):113-24
references.pmid: 6379379
references.citation: Neuroscience. 1985 Jun;15(2):313-26
references.pmid: 3895031
references.citation: J Neurosci Res. 1999 Jun 15;56(6):644-51
references.pmid: 10374819
references.citation: Nature. 1999 Jun 24;399(6738 Suppl):A32-9
references.pmid: 10392578
references.citation: Glia. 1999 Jul;27(1):62-74
references.pmid: 10401633
references.citation: J Neurosci. 1999 Jul 15;19(14):5990-6005
references.pmid: 10407037
references.citation: Int Immunol. 1999 Aug;11(8):1265-74
references.pmid: 10421784
references.citation: Immunol Rev. 1999 Jun;169:31-44
references.pmid: 10450506
references.citation: Science. 1999 Aug 20;285(5431):1236-41
references.pmid: 10455044
references.citation: Science. 1999 Aug 20;285(5431):1221-2
references.pmid: 10484730
references.citation: Exp Neurol. 1999 Oct;159(2):347-61
references.pmid: 10506507
references.citation: Proc R Soc Lond B Biol Sci. 1953 Jul 15;141(904):392-406
references.pmid: 13074176
references.citation: Transplantation. 1999 Oct 27;68(8):1153-60
references.pmid: 10551645
references.citation: Neuroscience. 2000;95(2):425-32
references.pmid: 10658622
references.citation: Neurology. 2000 Mar 14;54(5):1042-50
references.pmid: 10720272
references.citation: J Neurosci. 2000 May 1;20(9):3415-24
references.pmid: 10777804
references.citation: Cell Transplant. 2000 Mar-Apr;9(2):261-72
references.pmid: 10811398
references.citation: Glia. 1996 Jun;17(2):103-20
references.pmid: 8776578
references.citation: Neuroscience. 1996 Feb;70(3):775-89
references.pmid: 9045088
references.citation: Gene Ther. 1996 Jul;3(7):644-51
references.pmid: 8818653